BridgeMD
New treatment option for Chirurgical Intervention
Official title Effects of Osteopathic Management on Disability and Quality of Life After Lumbar Arthrodesis
ClinicalTrials.gov ID: NCT06802120
What this study is testing
- What it's testing
- The aim of our study is to assess the effect of a combined physiotherapy and osteopathy treatment versus a placebo on the management of disability and quality of life after lumbar arthrodesis. This study will provide a better assessment of the use of osteopathy as a non pharmacological approach to post-operative management.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- having experienced a lumbar arthrodesis (of one to three levels) four weeks before inclusion
- being under a stable pharmacological treatment over the last month
- who are suffering from postoperative mechanical pain (VAS ≥ 4)
You likely can't join if
- neuropathic pain according to a DN4 score greater than or equal to 4/10,
- are suffering from fibromyalgia,
- algodystrophy,
- other somatic or neuropsychiatric diseases (other than depression and anxiety),
- have received osteopathic treatment over the last three month prior to inclusion,
- are included in another treatment research protocol during the study period
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.